by Igor Volsky & Victoria Fleischer Aug 19, 2015
Did the FDA allow a slick public relations campaign to trump science?
by Igor Volsky & Victoria Fleischer Aug 14, 2015
An investigation by ThinkProgress reveals that the drug's public relations campaign is highly misleading and its effectiveness is moderate at best.
by Sam P.K. Collins Jul 29, 2015
They're supposed to report within 15 days.
by Tara Culp-Ressler Jun 2, 2015
The "blistering" comments came during an event that's sponsored by the pharmaceutical industry.
by Sam P.K. Collins May 4, 2015
“It’s striking that the drug prescribed to the most beneficiaries is a narcotic painkiller that can be addictive.”
by Sam P.K. Collins Apr 17, 2015
Here's how California is trying to fix it.
by Sam P.K. Collins Apr 15, 2015
"[The withholding of data] creates indirect costs for public and private entities, including patients themselves, who pay for sub-optimal or harmful treatments."
by Tara Culp-Ressler Mar 31, 2015
States are running out of places to get the drugs they need to execute inmates.
by Tara Culp-Ressler Mar 30, 2015
The country's leading group of pediatricians wants us to use milligrams.
by Tara Culp-Ressler Mar 26, 2015
This week, Americans who say they've been harmed by generic drugs are asking the FDA to crack down.